BELX was qualified for the company roadshow at the 6th China BioMed Innovation and Investment Conference (CBIIC),

marking its first step towards international collaboration in the Asia-Pacific region.

China BioMed Innovation and Investment Conference (CBIIC) is a high-profile platform for partnering

and is praised as the most important matchmaking summit in Asia-Pacific region,

it is organized by China Pharmaceutical Innovation Promotion Association

and co-organized by China Securities Association, China Medical Device Industry Association,

Hong Kong Stock Exchange, China Hospital Association, Randy International Think Tank

and Emeda Pharmaceutical Consulting.